Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension?
JACC: Heart Failure · 2024
DOI: 10.1016/j.jchf.2023.12.021 ↗Kurz gefasst
Editorial in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Nikhil Sikand und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: nikhil.sikand@yale.edu. Hauptthemen laut MEDLINE: Heart Failure, Hypertension, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address: nikhil.sikand@yale.edu.
- Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Zitieren
APA
Sikand, N., & Sen, S. (2024). Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension?. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.12.021
Vancouver
Sikand N, Sen S. Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension?. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2023.12.021
BibTeX
@article{Sikand2024,
author = {Sikand, Nikhil and Sen, Sounok},
title = {Are Cardiac Myosin Inhibitors Useful in Patients With Hypertrophic Obstructive Cardiomyopathy and Comorbid Hypertension?},
journal = {JACC: Heart Failure},
year = {2024},
doi = {10.1016/j.jchf.2023.12.021}
}
EUVIMED